Industry
Deals of The Day — Mergers and Acquisitions
The following bids, mergers, acquisitions and disposals were reported on Wednesday. The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Wednesday: Biogen Idec is to take full ownership of blockbuster multiple sclerosis drug Tysabri after agreeing to pay Irish partner Elan $3.
SEC puts Private Equity in its Sights
Securities and Exchange Commission said late last month that the agency has its eye on several private-equity industry practices
Private equity funds raised $40.3 bln for emerging markets-EMPEA
Emerging market private equity funds in 2012 had their best year for raising capital since 2008 Emerging market private equity funds in 2012 had their best year for raising capital since 2008, pulling in $40.
Carried interest thrust again into U.S. tax debate
A big tax break that benefits U.S. private equity and venture capital executives is under threat again
 




